logo-loader
CNSX:MDM

Marapharm Ventures Inc.

Receive alerts
Market:
CNSX
Market Cap:
£0.00
Price
£0.00
Change
0%
52 weeks high
0
52 weeks low
0

In brief

Marapharm Ventures Inc. (“ Marapharm” or the “Company”) is a developmental stage publicly traded medical marijuana company with operations based in British Columbia.

Through its wholly owned operating subsidiary Marapharm Inc., the Company has applied to Health Canada to become a licensed producer under the Marijuana for Medical Purposes Regulations (MMPR) issued pursuant to the Controlled Drugs and Substances Act (Canada). Marapharm’s initial facility, a proposed 22,000 sq.ft state-of-the-art designed-to-suit cultivation facility, will be constructed on an 11 acre leased site in Kelowna, British Columbia.

The Company’s growth strategy will be to build facilities or acquire licenses in the United States, determined by identifying opportunities and researching the direction and location of sales. The company has currently focused its attention on opportunities in Nevada and Washington.

Land has been purchased in Apex Business Park in the City of North Las Vegas, Nevada, for purposes of building a cultivation and production facility that will house three medical marijuana licenses.

In Washington, the Company has an opportunity to lease a facility to an I-502, tier 3 license holder. The licensee holds a production license for 30,000 sq’ and a processing license with unlimited potential.

Marapharm has also purchased and is developing an all-natural hemp oil product line called, Maragold, which will be ready for market within a few months.